JPMorgan Chase & Co. Has $398.19 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

JPMorgan Chase & Co. cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 75.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,265,689 shares of the exchange traded fund’s stock after selling 10,273,049 shares during the quarter. JPMorgan Chase & Co. owned about 4.89% of SPDR S&P Biotech ETF worth $398,186,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Legacy Wealth Managment LLC ID bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $32,000. Greykasell Wealth Strategies Inc. bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $35,000. Ballast Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $36,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $39,000. Finally, MCF Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $46,000.

SPDR S&P Biotech ETF Trading Down 1.9%

Shares of SPDR S&P Biotech ETF stock opened at $128.85 on Thursday. The firm has a fifty day simple moving average of $132.43 and a 200-day simple moving average of $126.96. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The stock has a market capitalization of $8.22 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.